Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

NCT05409365 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-06-10

No results posted yet for this study

Summary

This study aims to assess the expression of SCCA2 in the skin of patients with warts and to detect its correlation with characteristics of warts.

Conditions

  • Verruca Vulgaris
  • Healthy

Interventions

OTHER

Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody)

Immunohistochemical staining

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Ashraf Ahmed Abd El-Latif Abd El-Latif, Lecturer · Director

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-11-01
Completion
2023-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05409365 on ClinicalTrials.gov